关注
Charles Ethan Byrne
Charles Ethan Byrne
Research Scientist at AxoSim, Inc.
在 axosim.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Evaluation of intercellular communication between breast cancer cells and adipose-derived stem cells via passive diffusion in a two-layer microfluidic device
SM Rahman, JM Campbell, RN Coates, KM Render, CE Byrne, EC Martin, ...
Lab on a Chip 20 (11), 2009-2019, 2020
272020
Lignin-graft-PLGA drug-delivery system improves efficacy of MEK1/2 inhibitors in triple-negative breast cancer cell line
CE Byrne, CE Astete, M Vaithiyanathan, AT Melvin, M Moradipour, ...
Nanomedicine 15 (10), 981-1000, 2020
252020
Evaluation of extracellular matrix composition to improve breast cancer modeling
CE Byrne, JB Decombe, GC Bingham, J Remont, LG Miller, L Khalif, ...
Tissue Engineering Part A 27 (7-8), 500-511, 2021
202021
Quantifying breast cancer-driven fiber alignment and collagen deposition in primary human breast tissue
R Gurrala, CE Byrne, LM Brown, RFP Tiongco, MD Matossian, JJ Savoie, ...
Frontiers in Bioengineering and Biotechnology 9, 618448, 2021
172021
Breast Cancer-Stromal Interactions: Adipose-Derived Stromal/Stem Cell Age and Cancer Subtype Mediated Remodeling
KM Hamel, CT King, MB Cavalier, KQ Liimatta, GL Rozanski, TA King Jr, ...
Stem Cells and Development 31 (19-20), 604-620, 2022
52022
Modeling breast cancer in human breast tissue using a microphysiological system
LM Brown, KL Hebert, RR Gurrala, CE Byrne, M Burow, EC Martin, ...
JoVE (Journal of Visualized Experiments), e62009, 2021
52021
Expression of novel kinase MAP3K19 in various cancers and survival correlations
K Nguyen, H Yousefi, T Cheng, J Magrath, AB Hartono, M Alzoubi, ...
Frontiers in Bioscience-Landmark 27 (6), 196, 2022
32022
Liver Kinase B1 Regulates Remodeling of the Tumor Microenvironment in Triple-Negative Breast Cancer
CT King, MD Matossian, JJ Savoie, K Nguyen, MK Wright, CE Byrne, ...
Frontiers in molecular biosciences 9, 847505, 2022
32022
Xenohormetic Phytochemicals Inhibit Neovascularization in Microphysiological Models of Vasculogenesis and Tumor Angiogenesis
GW Kpeli, KM Conrad, W Bralower, CE Byrne, SM Boue, ME Burow, ...
Advanced Biology, 2300480, 2024
12024
Using an in vitro fluidics approach to model the evolution of metastatic breast cancer reveals shear stress as a possible driver of genomic instability and somatic …
M Bratton, CE Byrne, SM Rahman, CT King, CE Copeland, L Rhodes, ...
The FASEB Journal 33 (S1), lb175-lb175, 2019
12019
Ex vivo breast tumors for understanding the patient specific tumor microenvironment remodeling and drug responses
E Martin, M Benz, K Hebert, E Byrne, F Lau
Cancer Research 84 (6_Supplement), 3906-3906, 2024
2024
Adaptable Fabrication of Vascularized Milliscale Tissues in Membrane-Free Organ Chips Manufactured with 3D Printed Molds
CE Byrne, KM Conrad, AT Martier, GM Fortes, GW Kpeli, EA Olsen, ...
bioRxiv, 2023.12. 06.570409, 2023
2023
Breast cancer microphysiological systems based on human breast tissue
FH Lau, CE Byrne, L Brown, J Fontenot, RP Tiongco, RR Gurrala, ...
Cancer Research 82 (12_Supplement), 282-282, 2022
2022
Engineering a cisplatin-resistant lung cancer microenvironment to model recurrence of aggressive tumors following first line cytotoxic therapy
OM Ahmad, EA Olsen, DA Carlino, CE Byrne, M Mondrinos
Cancer Research 82 (12), 2022
2022
Organ chip culture of vascularized triple negative breast cancer explant tissues with validated pathological and clinically-targetable properties of tumor vasculature
KM Conrad, CE Byrne, MR Burow, M Mondrinos
Cancer Research 82 (12_Supplement), 285-285, 2022
2022
Accurately Quantifying Breast Cancer Driven Extracellular Matrix Fiber Alignment in Primary Human Breast Tissue
R Gurrala, EC Byrne, LM Brown, RFP Tiongco, EC Marrin, FH Lau
Journal of the American College of Surgeons 233 (5), e11, 2021
2021
A Multifaceted Biological Engineering Approach to Breast Cancer Modeling and Drug Delivery
CE Byrne
2020
Novel lignin-conjugated PLGA drug delivery system improves efficacy of MEK1/2 inhibitor in triple negative breast cancer
E Byrne, CE Astete, M Vaithiyanathan, AT Melvin, M Moradipour, ...
MOLECULAR CANCER THERAPEUTICS 18 (12), 2019
2019
Abstract A105: Novel lignin-conjugated PLGA drug delivery system improves efficacy of MEK1/2 inhibitor in triple negative breast cancer
E Byrne, CE Astete, M Vaithiyanathan, AT Melvin, M Moradipour, ...
Molecular Cancer Therapeutics 18 (12_Supplement), A105-A105, 2019
2019
SAT-LB055 Using Fluidics to Model the Genomic Evolution of Metastatic Breast Cancer
C Byrne, E Martin, A Melvin, S Rahman, C King, C Copeland, L Rhodes, ...
Journal of the Endocrine Society 3 (Supplement_1), SAT-LB055, 2019
2019
系统目前无法执行此操作,请稍后再试。
文章 1–20